#cell proliferation

Animal Tissue Culture 3

MTT assay measures:

MTT assay developed by Tim Mosmann in 1983 measures cell viability and proliferation based on reduction capacity of living cells. Principle uses yellow tetrazolium salt 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide which enters cells via endocytosis and is reduced by mitochondrial succinate dehydrogenase of complex II and cytosolic NAD(P)H-dependent oxidoreductases cleaving tetrazolium ring with electrons from NADH and NADPH producing insoluble purple formazan crystals accumulating intracellularly in mitochondria and lipid droplets. Metabolically incompetent dead cells fail to reduce MTT. After incubation 1-4 hours, medium removed and crystals solubilized in dimethyl sulfoxide or acidified isopropanol producing homogeneous purple solution quantified spectrophotometrically at 570 nm with reference 630 nm. Absorbance directly proportional to number of viable cells within linear range. Assay does not measure migration requiring Boyden chamber, DNA synthesis requiring BrdU incorporation, or specific protein expression requiring immunoassay. Applications include cytotoxicity screening, IC50 determination, chemosensitivity testing, and biocompatibility evaluation requiring validation with orthogonal methods. Proper controls including cell-free blanks and vehicle treatments correct for nonspecific dye reduction artifacts. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.

Ref: Mosmann T J Immunol Methods 1983 MTT viability assay; ATCC MTT Cell Proliferation Assay mitochondrial dehydrogenase reduction protocol.

View Details

Animal Tissue Culture 3

An advantage of EdU assay is:

Predominant advantage of EdU assay over BrdU is preservation of cellular architecture because it avoids harsh DNA denaturation. BrdU detection requires unwinding double helix using strong acid, heat, or enzymatic digestion to expose concealed bromo-deoxyuridine epitope for anti-BrdU antibody of large size 150 kDa that cannot access double-stranded DNA. These treatments hydrolyze fluorescent proteins such as GFP, destroy conformational epitopes of surface antigens CD markers, fragment histology, alter light scatter properties in flow cytometry, and distort cell cycle distributions. EdU click detection employs small organic azide dye around 1 kDa that diffuses freely into intact duplex forming covalent triazole without strand separation. Consequently morphology remains intact under phase-contrast, immunophenotype retains antigenicity enabling co-detection of stem markers, and compatibility with DNA content dyes propidium iodide or DAPI remains high without acid-induced artifacts. Sensitivity improves due to quantitative triazole formation, protocol duration reduces significantly, and multiplex capability expands making EdU preferred for tissue sections, whole mount embryos, and high-content imaging.

Ref: Buck et al Biotechniques 2008 EdU advantage no denaturation preserves antigens; Thermo Fisher Click-iT EdU vs BrdU no DNA denaturation needed.

View Details

Animal Tissue Culture 3

EdU assay differs from BrdU assay because it:

EdU, 5-ethynyl-2'-deoxyuridine, retains Watson-Crick pairing but bears terminal alkyne at 5 position instead of bromine. Detection utilizes bioorthogonal click chemistry specifically copper(I)-catalyzed azide-alkyne cycloaddition first described by Sharpless. In this reaction, alkyne on EdU incorporated into DNA reacts with fluorescent azide forming stable 1,2,3-triazole covalent linkage, catalyzed by CuSO4 reduced to Cu(I) by sodium ascorbate, proceeding rapidly in aqueous buffer at room temperature with exquisite specificity. Because fluorescent azide small molecule penetrates duplex DNA, harsh denaturation required for BrdU antibody access unnecessary. Standard BrdU assays need 2M hydrochloric acid, 95°C heat, or DNase digestion to unwind helix exposing brominated base for antibody binding, steps that destroy protein epitopes and fluorescent proteins. Click reaction eliminates antibody step, shortens protocol from overnight incubation to less than one hour, preserves morphology, and allows multiplexing with surface markers. Unlike radioactive thymidine labeling, EdU non-radioactive and bright. This advance revolutionized proliferation assessment. Nobel Prize in Chemistry 2022 recognized click chemistry applications transforming biological labeling and drug discovery. This knowledge strengthens laboratory safety, protocol reproducibility, and regulatory compliance critical for translational research and clinical applications, ensuring reliable data and workforce protection.

Ref: Salic A & Mitchison TJ PNAS 2008 EdU click chemistry; Kolb et al Click chemistry concept Nobel Prize 2022 CuAAC azide-alkyne.

View Details

Animal Tissue Culture 3

BrdU is a thymidine analog used to detect:

BrdU, 5-bromo-2'-deoxyuridine, is synthetic halogenated analog of thymidine where methyl group at 5 position replaced by bromine atom similar in size allowing Watson-Crick pairing with adenine during DNA synthesis. During S phase, DNA polymerases incorporate BrdU triphosphate from nucleotide pool into nascent strand in place of thymidine without halting polymerase at low micromolar concentrations. Incorporated BrdU detectable by specific anti-BrdU monoclonal antibodies after DNA denaturation exposes epitope, or by mass spectrometry. Assay quantifies fraction of cells actively replicating genome termed labeling index and S phase duration, monitors cell cycle kinetics, measures proliferation inhibition by cytotoxic agents via decreased incorporation, and tracks lineage in developmental biology through pulse-chase retaining label in slow-cycling stem cells while rapidly dividing progenitors dilute signal over successive divisions. Unlike puromycin incorporation marking protein synthesis or BrUTP marking nascent RNA transcripts, BrdU specifically reports DNA replication providing S phase specific information central to cancer and stem cell research.

Ref: Gratzner HG Science 1982 BrdU thymidine analog DNA replication detection; Alberts MBoC Ch.17 DNA synthesis S phase BrdU incorporation.

View Details

Cancer

Merlin (NF2) suppresses proliferation by

Sequestering growth factor receptors, is consistent with established principles of cell signaling, receptor pharmacology and cellular regulation. Experimental measurements of binding parameters, genetic loss-of-function studies and pharmacological interventions all converge on the same interpretation. Related options address neighboring concepts but do not satisfy the precise criterion stated in the question.